Latest Stock Research & Market Analysis
Search All Research, Articles & Stock Profiles
ASX Stock Research
[BUY] BlueScope Steel (ASX: BSL) – Capex Peaks and Cash Flow Inflects
BlueScope Steel (ASX: BSL) at A$32.00, on 6x forward EBITDA against steel peers near 7x. Capex has peaked and free cash flow inflects. Buy, about 18% upside.
[BUY] Aristocrat Leisure (ASX: ALL) – A Billion-Dollar Interactive Path
Aristocrat Leisure (ASX: ALL) at A$61.40, charting a path to US$1bn in Interactive revenue by FY29 as iGaming and iLotteries scale. Buy, around 14% upside.
[BUY] Worley (ASX: WOR) – Selloff Overshoots the Earnings Trim
Worley (ASX: WOR) at A$10.94, around 10x forward EV/EBIT after an overdone selloff. The earnings trim is modest, the growth case intact. Buy, about 35% upside.
[BUY] Worley (ASX: WOR) – Selloff Overshoots the Earnings Trim
Worley (ASX: WOR) at A$10.94, around 10x forward EV/EBIT after an overdone selloff. The earnings trim is modest, the growth case intact. Buy, about 35% upside.
[BUY] ResMed (ASX: RMD) – Growth Levers in Place for a Re-Rate
Buy ResMed at A$26.68 with a A$46.70 target and 75% upside. The GLP-1 fear is fading, new growth levers are scaling, and it trades below medtech peers.
Global Macro and Market Research
The Australian Consumer Was Already Last in the G10 on Spending. The RBA Hiked Anyway.
The G10 consumer dashboard puts Australian household spending growth dead last in the developed-market cohort. Tuesday’s RBA hike to 4.35 percent continues the squeeze. What that means for a domestic portfolio.
The Q1 CPI Was Mixed. The RBA Still Has to Hike on Tuesday.
The Reserve Bank Board meets on Monday and Tuesday next week with a rate decision at 2:30pm AEST on Tuesday. This is the most anticipated single-meeting call we have had in nine months. The case rests on a Q1 CPI print released on Wednesday that did two things at...
Why the Iran Oil Shock Points to More RBA Hikes, Not Fewer
The default narrative around the Iran conflict and the oil spike that has followed it is that it is bad news, full stop. Higher energy costs feed into inflation, dent consumer spending, and put pressure on central banks to either hold tight or cut rates to cushion the...
Global Stock Research
[BUY] MongoDB (MDB): The AI Data Layer Play With a Clear Path to $4bn Revenue
MongoDB (MDB) is rated a Buy with a US$360 price target, implying 8 per cent upside. The thesis rests on Atlas cloud consumption growth, an AI-native product strategy, and an earnings trajectory that compresses the P/E from 55x to 36x by FY29.
[BUY] Upwork (NASDAQ: UPWK) – Restructuring Sharpens the Margin Story
Upwork delivered a Q1'26 result that landed on the right side of a bifurcated narrative. Revenues came in around the midpoint of guidance at $195mn, while Adj. EBITDA of $57mn came in nearly 24% above consensus expectations, with the margin beat tracing back to a cost...
[BUY] Eli Lilly (LLY): Foundayo Reframes the Oral GLP-1 Story
LLY Buy with ~37% upside to ~US$1,283. 1Q26 EPS US$8.55 beat US$6.77, 2026 guide raised to US$82-85bn. Foundayo oral GLP-1 hits 8k prescribers in 3 weeks, 80% new incretin patients.
[BUY] Eli Lilly (LLY): Foundayo Reframes the Oral GLP-1 Story
LLY Buy with ~37% upside to ~US$1,283. 1Q26 EPS US$8.55 beat US$6.77, 2026 guide raised to US$82-85bn. Foundayo oral GLP-1 hits 8k prescribers in 3 weeks, 80% new incretin patients.
[HOLD] Tesla (NASDAQ: TSLA) A Strong Q1 But No Free Cash Flow Until 2028
Tesla (NASDAQ: TSLA) A Strong Q1 But No Free Cash Flow Until 2028 Tesla just delivered a first quarter result that was stronger than the market expected, with revenue beating the...
Region & Industry Outlook
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
ASX Announcement
Dicker Data (ASX: DDR) – Dicker Data H1 FY26 Interim Results
Dicker Data delivered a standout half-year result for H1 FY26, with net profit surging 54.1% to $60.7 million despite an increasingly competitive IT distribution landscape. Gross sales climbed 14.2% to $2.1 billion, marking a return to double-digit revenue growth and...
Harvey Norman Holdings (ASX: HVN) – Files FY26 Corporate Governance Statement
Harvey Norman Holdings Limited has lodged its Appendix 4G with the ASX, providing the key to its corporate governance disclosures for the financial year ended 30 June 2026. This filing serves as a roadmap for investors seeking to understand how the retailer has...
Harvey Norman Holdings (ASX: HVN) – Harvey Norman FY26 Results Presentation
Harvey Norman Holdings has demonstrated significant resilience in a challenging economic environment, reporting system sales of $9.64 billion for FY26, an increase of 3.1% on the prior year. The result underscores the durability of the retailer's diversified business...
Harvey Norman Holdings (ASX: HVN) – Harvey Norman FY26 Results Presentation
Harvey Norman Holdings has demonstrated significant resilience in a challenging economic environment, reporting system sales of $9.64 billion for FY26, an increase of 3.1% on the...
Harvey Norman Holdings (ASX: HVN) – Files FY26 Full Year Results
Harvey Norman Holdings reported underlying profit before tax of $654.69 million for the year ended 30 June 2026, a gain of $64.33 million or 10.9% compared with the prior year....
Top Stock Reports
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Subscribe
Want more Free Research?
Subscribe today for free and get an alert when we have new research and webinars.
MF & Co. Asset Management
MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.
We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.
Contact
Get In Touch
Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm
Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000